Australia · Delayed Price · Currency is AUD Telix Pharmaceuticals Statistics
Total Valuation
ASX:TLX has a market cap or net worth of AUD 5.39 billion. The enterprise value is 5.87 billion.
| Market Cap | 5.39B |
| Enterprise Value | 5.87B |
Important Dates
The next estimated earnings date is Thursday, October 15, 2026.
| Earnings Date | Oct 15, 2026 |
| Ex-Dividend Date | n/a |
Share Statistics
ASX:TLX has 339.78 million shares outstanding. The number of shares has increased by 2.75% in one year.
| Current Share Class | 339.78M |
| Shares Outstanding | 339.78M |
| Shares Change (YoY) | +2.75% |
| Shares Change (QoQ) | +5.42% |
| Owned by Insiders (%) | 14.84% |
| Owned by Institutions (%) | 44.40% |
| Float | 273.61M |
Valuation Ratios
The trailing PE ratio is 115.10 and the forward PE ratio is 445.81.
| PE Ratio | 115.10 |
| Forward PE | 445.81 |
| PS Ratio | 4.19 |
| PB Ratio | 7.65 |
| P/TBV Ratio | n/a |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Enterprise Valuation
| EV / Earnings | 121.16 |
| EV / Sales | 4.56 |
| EV / EBITDA | 52.31 |
| EV / EBIT | 73.44 |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 2.01, with a Debt / Equity ratio of 1.19.
| Current Ratio | 2.01 |
| Quick Ratio | 1.74 |
| Debt / Equity | 1.19 |
| Debt / EBITDA | 7.47 |
| Debt / FCF | -12.75 |
| Interest Coverage | 3.69 |
Financial Efficiency
Return on equity (ROE) is 7.37% and return on invested capital (ROIC) is 6.78%.
| Return on Equity (ROE) | 7.37% |
| Return on Assets (ROA) | 2.71% |
| Return on Invested Capital (ROIC) | 6.78% |
| Return on Capital Employed (ROCE) | 4.94% |
| Weighted Average Cost of Capital (WACC) | 6.62% |
| Revenue Per Employee | 1.12M |
| Profits Per Employee | 42,031 |
| Employee Count | 1,184 |
| Asset Turnover | 0.70 |
| Inventory Turnover | 12.58 |
Taxes
| Income Tax | -6.76M |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has increased by +3.66% in the last 52 weeks. The beta is 0.56, so ASX:TLX's price volatility has been lower than the market average.
| Beta (5Y) | 0.56 |
| 52-Week Price Change | +3.66% |
| 50-Day Moving Average | 16.05 |
| 200-Day Moving Average | 13.76 |
| Relative Strength Index (RSI) | 48.75 |
| Average Volume (20 Days) | 2,661,641 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, ASX:TLX had revenue of AUD 1.29 billion and earned 48.42 million in profits. Earnings per share was 0.14.
| Revenue | 1.29B |
| Gross Profit | 612.47M |
| Operating Income | 79.88M |
| Pretax Income | 41.66M |
| Net Income | 48.42M |
| EBITDA | 100.90M |
| EBIT | 79.88M |
| Earnings Per Share (EPS) | 0.14 |
Balance Sheet
The company has 364.14 million in cash and 838.19 million in debt, with a net cash position of -474.05 million or -1.40 per share.
| Cash & Cash Equivalents | 364.14M |
| Total Debt | 838.19M |
| Net Cash | -474.05M |
| Net Cash Per Share | -1.40 |
| Equity (Book Value) | 704.93M |
| Book Value Per Share | 2.07 |
| Working Capital | 355.13M |
Cash Flow
In the last 12 months, operating cash flow was -17.35 million and capital expenditures -48.40 million, giving a free cash flow of -65.75 million.
| Operating Cash Flow | -17.35M |
| Capital Expenditures | -48.40M |
| Depreciation & Amortization | 20.93M |
| Net Borrowing | 165.65M |
| Free Cash Flow | -65.75M |
| FCF Per Share | -0.19 |
Margins
Gross margin is 47.57%, with operating and profit margins of 6.20% and 3.76%.
| Gross Margin | 47.57% |
| Operating Margin | 6.20% |
| Pretax Margin | 3.24% |
| Profit Margin | 3.76% |
| EBITDA Margin | 7.84% |
| EBIT Margin | 6.20% |
| FCF Margin | n/a |
Dividends & Yields
ASX:TLX does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| FCF Payout Ratio | n/a |
| Buyback Yield | -2.75% |
| Shareholder Yield | -2.75% |
| Earnings Yield | 0.90% |
| FCF Yield | -1.22% |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | |
| Graham Upside |
Analyst Forecast
The average price target for ASX:TLX is 24.51, which is 54.44% higher than the current price. The consensus rating is "Buy".
| Price Target | 24.51 |
| Price Target Difference | 54.44% |
| Analyst Consensus | Buy |
| Analyst Count | 12 |
| Revenue Growth Forecast (3Y) | 15.76% |
| EPS Growth Forecast (3Y) | n/a |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
ASX:TLX has an Altman Z-Score of 3.19 and a Piotroski F-Score of 3.
| Altman Z-Score | 3.19 |
| Piotroski F-Score | 3 |